PL449204A1 - Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500 - Google Patents

Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500

Info

Publication number
PL449204A1
PL449204A1 PL449204A PL44920424A PL449204A1 PL 449204 A1 PL449204 A1 PL 449204A1 PL 449204 A PL449204 A PL 449204A PL 44920424 A PL44920424 A PL 44920424A PL 449204 A1 PL449204 A1 PL 449204A1
Authority
PL
Poland
Prior art keywords
bacteria
streptococcus salivarius
streptococcus
strain
salivarius
Prior art date
Application number
PL449204A
Other languages
English (en)
Inventor
Magdalena Jankowska
Natalia Czarnecka
Katarzyna Tupaj-Dziedzic
Grzegorz Czerwonka
Original Assignee
Regeneris Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneris Spółka Z Ograniczoną Odpowiedzialnością filed Critical Regeneris Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL449204A priority Critical patent/PL449204A1/pl
Publication of PL449204A1 publication Critical patent/PL449204A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest nowy szczep bakterii Streptococcus salivarius 500 zdeponowany w Polskiej Kolekcji Mikroorganizmów PCM w Instytucie Immunologii i Terapii Doświadczalnej Polskiej Akademii Nauk im. Ludwika Hirszfelda we Wrocławiu pod numerem B/00478 o właściwościach probiotycznych. Zgłoszenie zawiera także sposób inhibicji wzrostu bakterii patogennych za pomocą bakterii probiotycznych Streptococcus salivarius 500, charakteryzuje się tym, że stosuje się nowe bakterie probiotyczne Streptococcus salivarius 500 o numerze depozytu B/00478, które wykazują hamujące działanie wobec bakterii Gram-ujemnych Escherichia coli oraz Gram-dodatnich: Staphylococcus epidermidis, Streptococcus mutans, Streptococcus pyogenes, Enterococcus faecalis, Streptococcus agalactiae.
PL449204A 2024-07-11 2024-07-11 Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500 PL449204A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL449204A PL449204A1 (pl) 2024-07-11 2024-07-11 Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449204A PL449204A1 (pl) 2024-07-11 2024-07-11 Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500

Publications (1)

Publication Number Publication Date
PL449204A1 true PL449204A1 (pl) 2025-01-07

Family

ID=94174475

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449204A PL449204A1 (pl) 2024-07-11 2024-07-11 Nowy szczep bakterii Streptococcus salivarius 500 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Streptococcus salivarius 500

Country Status (1)

Country Link
PL (1) PL449204A1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023053073A1 (en) * 2021-09-30 2023-04-06 Blis Technologies Limited Probiotic enhancers and uses thereof
CN117143782A (zh) * 2023-10-30 2023-12-01 杭州微致生物科技有限公司 一种唾液链球菌嗜热亚种vb331及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023053073A1 (en) * 2021-09-30 2023-04-06 Blis Technologies Limited Probiotic enhancers and uses thereof
CN117143782A (zh) * 2023-10-30 2023-12-01 杭州微致生物科技有限公司 一种唾液链球菌嗜热亚种vb331及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. BIDOSSI I IN.,: "BMC Infectious Diseases, 2028, 18:653", PROBIOTICS STREPTOCOCCUS SALIVARIUS 24SMB AND STREPTOCOCCUS ORALIS 89A INTERFERE WITH BIOFILM FORMATION OF PATHOGENS OF THE UPPER RESPIRATORY TRACT, DOI: https://doi.org/10.1186/s12879-018-3576-9 *
STAŠKOVÁ, A. I IN.,: "Antibiotics, 2021, 10, 793.", ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY OF THE PROBIOTIC STRAIN STREPTOCOCCUS SALIVARIUS K12 AGAINST ORAL POTENTIAL PATHOGENS, DOI: https://doi.org/10.3390/antibiotics10070793 *

Similar Documents

Publication Publication Date Title
Guglielmetti et al. Oral bacteria as potential probiotics for the pharyngeal mucosa
Fux et al. Survival strategies of infectious biofilms
Carlson et al. Antimicrobial susceptibility of Arcanobacterium haemolyticum
Stern et al. Bacteriocins reduce Campylobacter jejuni colonization while bacteria producing bacteriocins are ineffective
Ukena et al. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1
JP2010534063A5 (pl)
JP2017533197A5 (pl)
CN108753646B (zh) 一株对革兰阳性耐药菌具有广谱抗菌活性的人葡萄球菌及其筛选方法和应用
Deshpande et al. Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
Heidari et al. Antimicrobial activity of cyanobacteria isolated from hot spring of Geno
Al-Kafaween et al. Pseudomonas aeruginosa and Streptococcus pyogenes exposed to Malaysian trigona honey in vitro demonstrated downregulation of virulence factor
Al-Shuneigat et al. Effects of wild Thymus vulgaris essential oil on clinical isolates biofilm-forming bacteria
Darnell et al. Genomewide profiling of the Enterococcus faecalis transcriptional response to teixobactin reveals CroRS as an essential regulator of antimicrobial tolerance
Tang et al. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis
Nomoto et al. Totally implantable venous access port infection caused by Staphylococcus pseudintermedius: possible transmission from a companion dog to a human
JP2017533177A5 (pl)
PL449203A1 (pl) Nowy szczep bakterii Lacticaseibacillus rhamnosus 484 oraz sposób inhibicji bakterii patogennych z wykorzystaniem szczepu bakteryjnego z gatunku Lacticaseibacillus rhamnosus 484
JONES et al. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin
Karim et al. Bacterial isolates in neutropenic febrile patients
Chemaly et al. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2
Jeong et al. Genetic diversity of the tet (M) gene in tetracycline-resistant oral streptococci
MARIA et al. ANTIMICROBIAL ACTIVITY OF A METHANOLIC EXTRACT OF KALANCHOE DAIGREMONTIANA RAYM.-HAMET AND H. PERRIER AGAINST SALMONELLA TYPHI ATCC 6589
Savini et al. First report of vaginal infection caused by Enterococcus raffinosus
PL435199A1 (pl) Kompozycja bakteriofagów specyficzna wobec bakterii z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli, zastosowanie kompozycji bakteriofagów do leczenia zakażeń wywołanych przez bakterie z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli oraz zastosowanie kompozycji bakteriofagów jako czynnika biokontroli
Tong et al. In vitro study of the properties of Streptococcus mutans in starvation conditions